EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing

Blake Neil, Gabrielle L Cheney, Jason A Rosenzweig, Jian Sha, Ashok K Chopra

Applied Microbiology and Biotechnology · 2024-12 · 108 (1)

DOI: 10.1007/s00253-024-13055-z ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 13.02.2024. Verfasst von Blake Neil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Medical Branch, University of Texas, Galveston, TX, 77555, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cross Infection. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Foundation for the National Institutes of Health, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aeromonas species (spp.) are well-known fish pathogens, several of which have been recognized as emerging human pathogens. The organism is capable of causing a wide spectrum of diseases in humans, ranging from gastroenteritis, wound infections, and septicemia to devastating necrotizing fasciitis. The systemic form of infection is often fatal, particularly in patients with underlying chronic diseases. Indeed, recent trends demonstrate rising numbers of hospital-acquired Aeromonas infections, especially in immuno-compromised individuals. Additionally, Aeromonas -associated antibiotic resistance is an increasing challenge in combating both fish and human infections. The acquisition of antibiotic resistance is related to Aeromonas ’ innate transformative properties including its ability to share plasmids and integron-related gene cassettes between species and with the environment. As a result, alternatives to antibiotic treatments are desperately needed. In that vein, many treatments have been proposed and studied extensively in the fish-farming industry, including treatments that target Aeromonas quorum sensing. In this review, we discuss current strategies targeting quorum sensing inhibition and propose that such studies empower the development of novel chemotherapeutic approaches to combat drug-resistant Aeromonas spp. infections in humans. Key points • Aeromonas notoriously acquires and maintains antimicrobial resistance, making treatment options limited. • Quorum sensing is an essential virulence mechanism in Aeromonas infections. • Inhibiting quorum sensing can be an effective strategy in combating Aeromonas infections in animals and humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCross InfectionAnimalsHumansQuorum SensingDrug Resistance, BacterialAgriculture

Stichwörter der Autor:innen

AeromonasAntimicrobial resistanceHorizontal gene transferQuorum sensingQuorum sensing inhibition

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Medical Branch, University of Texas, Galveston, TX, 77555, USA.
  • John Sealy School of Medicine, Medical Branch, University of Texas, Galveston, TX, 77555, USA.
  • Department of Biology, Texas Southern University, Houston, TX, 77004, USA.
  • Department of Microbiology and Immunology, Medical Branch, University of Texas, Galveston, TX, 77555, USA. achopra@utmb.edu.

Förderung

  • NIAID NIH HHS
  • Foundation for the National Institutes of Health
  • National Science Foundation

Zitieren

APA

Neil, B., Cheney, G. L., Rosenzweig, J. A., Sha, J., & Chopra, A. K. (2024). Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing. Applied Microbiology and Biotechnology, 108(1). https://doi.org/10.1007/s00253-024-13055-z

Vancouver

Neil B, Cheney GL, Rosenzweig JA, Sha J, Chopra AK. Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing. Applied Microbiology and Biotechnology. 2024;108(1). doi:10.1007/s00253-024-13055-z

BibTeX
@article{Neil2024,
  author = {Neil, Blake and Cheney, Gabrielle L and Rosenzweig, Jason A and Sha, Jian and Chopra, Ashok K},
  title = {Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  volume = {108},
  number = {1},
  doi = {10.1007/s00253-024-13055-z}
}
Kostenlos starten →